María Teresa Melgarejo Segura

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Drug Administration

Muscle Invasive Bladder Cancer

Top Venues

Bladder cancer (Amsterdam, Netherlands)

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Ángel Arrabal Polo, María Teresa Melgarejo Segura, Yaiza María Yáñez-Castillo, Ana Morales Martínez, Manuel Pareja Vílchez, Miguel Arrabal
Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study. Journal of cancer research and clinical oncology (2023)
María Teresa Melgarejo Segura, Ana Morales Martínez, Yaiza Yáñez Castillo, Miguel Ángel Arrabal Polo, Francisco Gutiérrez Tejero, Manuel Pareja Vílchez, Miguel Arrabal
Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer. Bladder cancer (Amsterdam, Netherlands) 9 (2) (2023)
Miguel Ángel Arrabal Polo, María Teresa Melgarejo Segura, Yaiza María Yáñez-Castillo, Ana Morales Martínez, Manuel Pareja Vílchez, Miguel Arrabal
Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study. Journal of cancer research and clinical oncology (2023)
María Teresa Melgarejo Segura, Ana Morales Martínez, Yaiza Yáñez Castillo, Miguel Ángel Arrabal Polo, Francisco Gutiérrez Tejero, Manuel Pareja Vílchez, Miguel Arrabal
Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer. Bladder cancer (Amsterdam, Netherlands) 9 (2) (2023)